| (Values in U.S. Thousands) | Jun, 2022 | Mar, 2022 | Dec, 2021 | Sep, 2021 | Jun, 2021 |
| Sales | 70 | 190 | 180 | 0 | 1,610 |
| Sales Growth | -63.16% | +5.56% | unch | -100.00% | +5,266.67% |
| Net Income | -2,080 | -1,340 | -3,460 | -1,430 | -900 |
| Net Income Growth | -55.22% | +61.27% | -141.96% | -58.89% | +71.25% |
Gbs Inc (GBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
GBS Inc. is a life sciences company. It engages in developing non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care. GBS Inc. is based in NEW YORK.